POSIJET® Shielded radiopharmaceutical injection and preparation unit

Posijet® offers an unrivaled ease-of-use for preparation and injection of high energy radiopharmaceuticals while guaranteeing highest security conditions and radiation protection for both the user and the patient while guaranteeing the integrity of the radioactive drug.

This compact, self-contained, radiation protected radiopharmaceutical fractionating and injection unit supports all multi-dose fluorinated tracers (¹⁸F) including ¹⁸F-FDG, ¹⁸F-DOPA, ¹⁸F-CHOLINE, ¹⁸F-FNA, ¹⁸F-PSMA … and also tracers labelled with ⁶⁸Ga, as well as Ammonia labelled with ¹³N for cardiac PET examinations.

With its new “Therapy” application, it is also able to perform slow administrations in 30 minutes, for Vectorised Internal Radiation Therapy (VIR) treatments. Especially with ¹⁷⁷Lu labelled radiopharmaceuticals (¹⁷⁷Lu octreotate or ¹⁷⁷Lu DOTA-TATE, ¹⁷⁷Lu-PSMA-617 …).

It is also possible to perform fractionating and intravenous administration of ^99mTc-labelled SPECT radiopharmaceuticals.For routine diagnostic applications, Posijet® features a very fine sampling capacity of 100 μL of the stock solution with an average dose preparation time of 50 seconds and an accuracy of around 2 %. The average injection time, including rinsing operations, is less than 1 minute 30 seconds.

• Efficiency : 100 % of the mother solution is used
• Injection accuracy : (+/- 2%)
• Ease of use : motorised assistance
• Reliability : connectivity, remote maintenance
• Battery autonomy : 8h after 2 h battery loading
• Efficiency: Option to inject two patients simultaneously using the peripheral injection system (optional)